Intralesional MMR in WARTS: A Research Article

Abstract

Warts are benign epidermal tumor caused by human papilloma virus. Immunotherapy appears 
to enhance virus recognition by immune system, allowing clearance of treated wart, distant
warts and helps to prevent infection.0.5 ml intralesional MMR vaccine into a single wart or
the largest wart in case of multiple lesions. Intralesional vaccine was given every 02 weeks 
into the same wart for 03 doses. Intralesional immunotherapy with MMR vaccine was found 
to be a simple, effective, and safe treatment for warts. This study proved to be cost effective
as patients can be treated with just 03 doses of MMR vaccine given at the interval of two
weeks.